So-Young International (ADR) (SY)
Connects medical-aesthetics information, reservations, branded centers, and supply-chain services in China.
Something off on this page? Send us feedback.
Provides information, community content, and offline reservations for medical-aesthetic treatments in China. The model combines an online platform with branded aesthetic centers and medical-product supply-chain services.
Connects people considering medical-aesthetic treatments with information, community content, and offline reservations in China. Information and reservation services remain the core of its online platform, which began as a place to research treatments and share experiences.
Combines that platform with branded aesthetic-treatment centers and supply-chain services for medical equipment and injectable products, extending its role across more of the treatment journey. Operations depend on digital-platform execution as well as the clinical, regulatory, and operating requirements of its offline network. The Cayman issuer uses contractual arrangements with affiliated entities in China.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 8, 2025 | Citigroup | Upgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $126.6M · Total debt $56.5M · Total assets $399.9M · Shareholders' equity $218.1M
- Revenue
- $75.2M
- Operating income
- −$6.5M
- Net income
- −$3.4M
Reported in CNY, converted at the latest exchange rate
HistoryDividendAnnual yield
| Institutions | 18.75% | 24.60M ADS | |
|---|---|---|---|
| 30 holders · as of Jun 30, 2026 | |||
| Other | 81.25% | 106.61M ADS | |
| remainder | |||
131.21M ADS as of Sep 21, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
The share count has not been confirmed by a second filing; stakes use it as it stands.
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
This company has 3 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
TB Alternative Assets Ltd.Institution | 7.01% | 3.07M A ADS · 3.07M A ADS · 3.07M A ADS | as of Jun 30, 2026 |
Morgan StanleyInstitution | 2.82% | 1.23M A ADS · 1.23M A ADS · 1.23M A ADS | as of Jun 30, 2026 |
Barclays PLCInstitution | 2.58% | 1.13M A ADS · 1.13M A ADS · 1.13M A ADS | as of Jun 30, 2026 |
Citigroup IncInstitution | 2.37% | 1.04M A ADS · 1.04M A ADS · 1.04M A ADS | as of Jun 30, 2026 |
UBS Group AGInstitution | 1.02% | 446,553 A ADS · 446,553 A ADS · 446,553 A ADS | as of Jun 30, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
Not reported.